Coronary CT Angiography (CCTA) Procedures Market Size, Share, and Industry Analysis, By Indication (Suspected Coronary Artery Disease, Pre-Operative Cardiac Risk Assessment, Post-Revascularization Assessment, and Others), By Setting (Hospitals, Independent Diagnostic Imaging Centers, and Others), and Regional Forecast till 2034

The coronary CT angiography (CCTA) procedures market size was valued at USD 5.48 billion in 2025 and is expected to reach a market valuation of USD 5.79 billion in 2026. Furthermore, the market is projected to reach a market valuation of USD 9.00 billion by 2034, exhibiting a CAGR of 5.7% during the forecast period.

The market growth is attributed to increasing recommendations of CCTA as a first-line test for evaluating stable chest pain and suspected coronary artery disease (CAD), reducing reliance on invasive coronary angiography for low- to intermediate-risk patients.

Coronary CT Angiography (CCTA) Procedures Market Driver

Growing Burden of Coronary Artery Disease and Preventive Screening to Drive the Market Growth

In recent years, there have been an increasing cases of coronary artery diseases due to an aging population, rising obesity rates, sedentary lifestyles, and higher diabetes prevalence. This is driving the need for early diagnosis and preventive cardiology, surging the demand for CCTA procedures due to its ability to visualize coronary plaque non-invasively. Such a scenario is expected to fuel the market expansion in the forthcoming years.

• For instance, according to the data published by the British Heart Foundation in January 2026, around 2.3 million people in the U.K. were suffering from coronary heart disease, a widespread medical condition.

Download Free sample to learn more about this report.

According to data published by the British Heart Foundation in January 2026, in the U.K., 2.3 million people live with coronary heart disease (CHD), including approximately 1.5 million men and over 0.8 million women.

Coronary CT Angiography (CCTA) Procedures Market Restraint

Shortage of Radiologists and Limited Reimbursements to Hamper the Market Growth

In several countries, there is a scarcity of radiologists in healthcare facilities, which is expected to delay the number of procedures, leading to unmet demand. Also, reimbursement rates for CCTA are limited in several regions, which is expected to restrict scan volumes. Such a scenario is anticipated to hamper the market expansion.

• For instance, in June 2025, the Radiological Society of North America (RSNA) released a new report on the radiology shortage, stating that there were 13 radiologists per 100,000 people in the U.S.

Coronary CT Angiography (CCTA) Procedures Market Opportunity

Expansion of FFR-CT and Functional Assessment Integration to Offer Lucrative Growth Opportunity

In recent years, the integration of AI-driven FFR-CT analysis has enhanced CCTA from purely anatomical imaging to combined anatomical-functional evaluation. This has reduced unnecessary invasive angiography and improved patient stratification. Moreover, as reimbursement pathways for FFR-CT expand, adoption is expected to increase in North America and Europe, offering significant opportunities for market growth.

Segmentation

Key Insights

The report covers the following key insights:

• Number of CCTA Procedures, by Key Countries/Region, 2025
• Overview of Reimbursement Scenario
• Key Industry Developments - (Partnerships, Mergers, and Acquisitions, etc.)

Analysis by Indication

By indication, the market is segmented into suspected coronary artery disease, pre-operative cardiac risk assessment, post-revascularization assessment, and others.

The suspected coronary artery disease segment is expected to hold the major share of the global market during the forecast period. The segment’s growth is attributed to the use of CCTA as a first-line imaging modality for patients with stable chest pain and an intermediate pre-test probability of CAD, which has increased procedure volume.

Analysis by Setting

Based on setting, the market is divided into hospitals, independent diagnostic imaging centers, and others.

The hospital-based dialysis units segment is expected to hold the largest share of the global market during the forecast period. The growth is attributed to a significant proportion of CCTA procedures performed in hospital emergency departments for acute chest pain triage, access to Advanced CT Infrastructure, and the capability for complex case handling. Also, significant reimbursements in these settings are leading to an increase in patient volumes.

• For instance, according to the CMS 2025 HOPPS final rule, payment rates for coronary computed tomography angiography (CCTA) will double next year.

Regional Analysis

Request for Customization   to gain extensive market insights.

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for a 39.9% share of the global coronary CT angiography (CCTA) procedures market in 2025. The growth is attributed to a strong network of independent diagnostic imaging centers and favorable reimbursement, which is leading to a higher recommendation rate of CCTA for CAD and other conditions in the region.

• For instance, in February 2026, RadNet Inc. is the leading U.S. provider of outpatient imaging services, operating 430 centers across the country.

Asia Pacific is expected to grow at the highest CAGR during the forecast period. The region’s growth is attributed to the rapid expansion of healthcare infrastructure, rising cardiovascular disease burden, and rising middle-class healthcare spending in emerging markets such as India, China, and South Korea.

Key Players Covered

The global coronary CT angiography (CCTA) procedures market is highly fragmented, with large tertiary hospitals and expanding outpatient imaging networks dominating. Also, the competition is driven by technological capabilities, pricing efficiency, referral networks, and others.

The report includes the profiles of the following key players:

• Mayo Foundation for Medical Education and Research (MFMER) (U.S.)
• Cleveland Clinic (U.S.)
• Johns Hopkins Hospital (U.S.)
• SimonMed Imaging (U.S.)
• RadNet, Inc. (U.S.)
• University Hospital Zurich (Switzerland)
• Bupa Cromwell Hospital (U.K.)
• Seoul National University Hospital (South Korea)
• Apollo Hospitals (India)
• Akumin Inc. (U.S.)

Key Industry Developments

• February 2024: LucidHealth, Inc., and HCA Southern Hills Hospital & Medical Center entered into a partnership to bring advanced radiology services to the Las Vegas community.
• May 2023: Envision Radiology and HCA Healthcare formed a joint venture to open a USD 3.5 million outpatient imaging center in Tallahassee, Florida.